Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort

Menopausal hormone therapy and risk of cholecystectomy: a prospective study based on the French E3N cohort

(2013) A. Racine et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women’s Health Initiative Observational Study

(2013) Rowan T. Chlebowski et al.   JNCI-Journal of the National Cancer Institute

Declining incidence of breast cancer after decreased use of hormone-replacement therapy: magnitude and time lags in different countries

(2011) Kevin Zbuk et al.   JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH

Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy

(2011) V. Beral et al.   JNCI-Journal of the National Cancer Institute

Menopausal Hormone Therapy and Risk of Endometrial Carcinoma Among Postmenopausal Women in the European Prospective Investigation into Cancer and Nutrition

(2010) N. E. Allen et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Menopausal Hormone Therapy and Subsequent Risk of Specific Invasive Breast Cancer Subtypes in the California Teachers Study

(2010) T. Saxena et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Postmenopausal hormone use and breast cancer associations differ by hormone regimen and histologic subtype

(2009) Eugenia E. Calle et al.   CANCER

Estrogen-Progestagen Menopausal Hormone Therapy and Breast Cancer: Does Delay From Menopause Onset to Treatment Initiation Influence Risks?

(2009) Agnès Fournier et al.   JOURNAL OF CLINICAL ONCOLOGY

Agreement of self-reported estrogen use with prescription data

(2009) Lorenzo Sandini et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal Women

(2009) Rowan T. Chlebowski et al.   NEW ENGLAND JOURNAL OF MEDICINE

Menopausal Hormone Therapy and Breast Cancer Risk in the NIH-AARP Diet and Health Study Cohort

(2008) L. A. Brinton et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Use of Different Postmenopausal Hormone Therapies and Risk of Histology- and Hormone Receptor–Defined Invasive Breast Cancer

(2008) Agnès Fournier et al.   JOURNAL OF CLINICAL ONCOLOGY

A review of human carcinogens—Part A: pharmaceuticals

(2008) Yann Grosse et al.   LANCET ONCOLOGY

Did the decrease in use of menopausal hormone therapy induce a decrease in the incidence of breast cancer in France (and elsewhere)?

(2008) V. Ringa et al.   REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE